Our clinical and cellular data indicating potential associations between FILIP1L and SLUG led us to hypothesize that FILIP1L blocks EMT in ovarian cancer by virtue of decreasing the pool of active β-catenin. Here, FILIP1L is linked to ovarian cancer.